Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibrosarcoma × Liquid Biopsy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 8 Lung Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 5 Neoplastic Cells, Circulating 4 Biliary Tract Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Neoplasm, Residual 3 Neoplasm Metastasis 3 Disease 3 Nevi and Melanomas 2 Neuroendocrine Tumors 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Head and Neck Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Hepatocellular 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking 1 Sarcoma, Ewing 1

Interventions

Doxorubicin 15 Ifosfamide 10 Radiotherapy 5 selinexor 4 pazopanib 4 Filgrastim 4 pembrolizumab 3 pegfilgrastim 3 Sirolimus 3 Magnetic Resonance Spectroscopy 3 AZD 6244 3 fludarabine phosphate 2 brostallicin 2 X-Rays 2 Trabectedin 2 Specimen Handling 2 Sorafenib 2 Nivolumab 2 Imatinib Mesylate 2 Etoposide 2 Biopsy 2 thymoglobulin 1 temsirolimus 1 tazemetostat 1 sotigalimab 1 ribociclib 1 pexidartinib 1 perifosine 1 metarrestin 1 lorvotuzumab mertansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06515860 2026-01-09

NF1-TED

Boston Children's Hospital

Neurofibromatosis 1, Neurofibroma, Plexiform, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡